- Home
- OPAD vs ATRA Comparison
OPAD vs ATRA Comparison
Compare OPAD & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPAD | ATRA |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | 140 | N/A |
| Industry | Real Estate | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.5M | 38.9M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | OPAD | ATRA |
|---|---|---|
| Price | $0.72 | $5.11 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 4 | 2 |
| Target Price | $1.83 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 688.4K | 244.1K |
| Earning Date | 05-04-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | N/A | ★ 2.57 |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $32.08 | N/A |
| P/E Ratio | ★ N/A | $1.84 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.57 | $3.92 |
| 52 Week High | $6.35 | $19.15 |
Technical Indicators
Market Signals| Indicator | OPAD | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 48.65 | 48.90 |
| Support Level | $0.71 | $4.70 |
| Resistance Level | $0.82 | $5.65 |
| Average True Range (ATR) | 0.06 | 0.48 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 71.71 | 32.41 |
Price Performance
Historical ComparisonAbout OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services, including mortgage, listing, renovation, and buyer representation services.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).